FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381434039> ?p ?o ?g. }

• W4381434039 endingPage "4850" @default.
• W4381434039 startingPage "4850" @default.
• W4381434039 abstract "Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Despite the existence of various therapeutic options, NSCLC is still a major health concern due to its aggressive nature and high mutation rate. Consequently, HER3 has been selected as a target protein along with EGFR because of its limited tyrosine kinase activity and ability to activate PI3/AKT pathway responsible for therapy failure. We herein used a BioSolveIT suite to identify potent inhibitors of EGFR and HER3. The schematic process involves screening of databases for constructing compound library comprising of 903 synthetic compounds (602 for EGFR and 301 for HER3) followed by pharmacophore modeling. The best docked poses of compounds with the druggable binding site of respective proteins were selected according to pharmacophore designed by SeeSAR version 12.1.0. Subsequently, preclinical analysis was performed via an online server SwissADME and potent inhibitors were selected. Compound 4k and 4m were the most potent inhibitors of EGFR while 7x effectively inhibited the binding site of HER3. The binding energies of 4k, 4m, and 7x were -7.7, -6.3 and -5.7 kcal/mol, respectively. Collectively, 4k, 4m and 7x showed favorable interactions with the most druggable binding sites of their respective proteins. Finally, in silico pre-clinical testing by SwissADME validated the non-toxic nature of compounds 4k, 4m and 7x providing a promising treatment option for chemoresistant NSCLC." @default.
• W4381434039 created "2023-06-21" @default.
• W4381434039 creator A5003144386 @default.
• W4381434039 creator A5005596542 @default.
• W4381434039 creator A5019780164 @default.
• W4381434039 creator A5026723542 @default.
• W4381434039 creator A5032643025 @default.
• W4381434039 creator A5063660282 @default.
• W4381434039 creator A5083023309 @default.
• W4381434039 date "2023-06-19" @default.
• W4381434039 modified "2023-09-27" @default.
• W4381434039 title "Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer" @default.
• W4381434039 cites W1575111648 @default.
• W4381434039 cites W1981981363 @default.
• W4381434039 cites W1991198394 @default.
• W4381434039 cites W2009357736 @default.
• W4381434039 cites W2014066416 @default.
• W4381434039 cites W2023050422 @default.
• W4381434039 cites W2078636414 @default.
• W4381434039 cites W2087959032 @default.
• W4381434039 cites W2089248273 @default.
• W4381434039 cites W2090685720 @default.
• W4381434039 cites W2108492672 @default.
• W4381434039 cites W2114779636 @default.
• W4381434039 cites W2129992678 @default.
• W4381434039 cites W2136343696 @default.
• W4381434039 cites W2139236349 @default.
• W4381434039 cites W2157884341 @default.
• W4381434039 cites W2160592148 @default.
• W4381434039 cites W2161821474 @default.
• W4381434039 cites W2175130792 @default.
• W4381434039 cites W2176516200 @default.
• W4381434039 cites W2184779060 @default.
• W4381434039 cites W2466033276 @default.
• W4381434039 cites W2507186170 @default.
• W4381434039 cites W2588635793 @default.
• W4381434039 cites W2593436234 @default.
• W4381434039 cites W2620998958 @default.
• W4381434039 cites W2726680883 @default.
• W4381434039 cites W2770621380 @default.
• W4381434039 cites W2772768082 @default.
• W4381434039 cites W2804673751 @default.
• W4381434039 cites W2806275221 @default.
• W4381434039 cites W2893535613 @default.
• W4381434039 cites W2899070097 @default.
• W4381434039 cites W2916654072 @default.
• W4381434039 cites W2921157435 @default.
• W4381434039 cites W2967091608 @default.
• W4381434039 cites W2986790007 @default.
• W4381434039 cites W3044687690 @default.
• W4381434039 cites W3094640617 @default.
• W4381434039 cites W3095185799 @default.
• W4381434039 cites W3104001257 @default.
• W4381434039 cites W3116026823 @default.
• W4381434039 cites W3133195764 @default.
• W4381434039 cites W3134285223 @default.
• W4381434039 cites W3169321271 @default.
• W4381434039 cites W3205993471 @default.
• W4381434039 cites W3210182502 @default.
• W4381434039 cites W4281744860 @default.
• W4381434039 cites W4318946569 @default.
• W4381434039 cites W4320302672 @default.
• W4381434039 cites W4324344607 @default.
• W4381434039 doi "https://doi.org/10.3390/molecules28124850" @default.
• W4381434039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37375404" @default.
• W4381434039 hasPublicationYear "2023" @default.
• W4381434039 type Work @default.
• W4381434039 citedByCount "0" @default.
• W4381434039 crossrefType "journal-article" @default.
• W4381434039 hasAuthorship W4381434039A5003144386 @default.
• W4381434039 hasAuthorship W4381434039A5005596542 @default.
• W4381434039 hasAuthorship W4381434039A5019780164 @default.
• W4381434039 hasAuthorship W4381434039A5026723542 @default.
• W4381434039 hasAuthorship W4381434039A5032643025 @default.
• W4381434039 hasAuthorship W4381434039A5063660282 @default.
• W4381434039 hasAuthorship W4381434039A5083023309 @default.
• W4381434039 hasBestOaLocation W43814340391 @default.
• W4381434039 hasConcept C103697762 @default.
• W4381434039 hasConcept C104317684 @default.
• W4381434039 hasConcept C10679952 @default.
• W4381434039 hasConcept C121608353 @default.
• W4381434039 hasConcept C126322002 @default.
• W4381434039 hasConcept C143998085 @default.
• W4381434039 hasConcept C185592680 @default.
• W4381434039 hasConcept C2775905019 @default.
• W4381434039 hasConcept C2776256026 @default.
• W4381434039 hasConcept C42362537 @default.
• W4381434039 hasConcept C502942594 @default.
• W4381434039 hasConcept C55493867 @default.
• W4381434039 hasConcept C56173144 @default.
• W4381434039 hasConcept C62478195 @default.
• W4381434039 hasConcept C70721500 @default.
• W4381434039 hasConcept C71924100 @default.
• W4381434039 hasConcept C74187038 @default.
• W4381434039 hasConcept C86803240 @default.
• W4381434039 hasConcept C98274493 @default.
• W4381434039 hasConceptScore W4381434039C103697762 @default.
• W4381434039 hasConceptScore W4381434039C104317684 @default.

• next